ATE226072T1 - INHIBITING SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXYCARBAZOLE COMPOUNDS - Google Patents
INHIBITING SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXYCARBAZOLE COMPOUNDSInfo
- Publication number
- ATE226072T1 ATE226072T1 AT95902689T AT95902689T ATE226072T1 AT E226072 T1 ATE226072 T1 AT E226072T1 AT 95902689 T AT95902689 T AT 95902689T AT 95902689 T AT95902689 T AT 95902689T AT E226072 T1 ATE226072 T1 AT E226072T1
- Authority
- AT
- Austria
- Prior art keywords
- proliferation
- smooth muscle
- hydroxycarbazole
- compounds
- hydroxycarbazole compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
The present invention provides a new medical use of the hydroxycarbazole compounds of Formula (I), preferably the hydroxylated metabolites of 1-(carbazol-4-yloxy-3-[[2-(o-methoxyphenoxy)ethyl]amino]-2-propanol)(carvedilol), for inhibiting the migration and proliferation of smooth muscle cells. In particular, the present invention provides a new use for the hydroxycarbazole compounds of Formula (I) for prevention of restenosis following percutaneous transluminal coronary angioplasty (PTCA), suppression of the progression of vascular hypertrophy associated with hypertension, and prevention of development of atherosclerosis. <IMAGE> (I) wherein: R1-R9 are independently -H or -OH, with the proviso that a at least one of R1-R9 is OH.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/157,588 US5393772A (en) | 1993-11-24 | 1993-11-24 | Use of, and method of treatment using, hydroxycarbazole compounds for inhibition of smooth muscle migration and proliferation |
PCT/US1994/013561 WO1995014384A1 (en) | 1993-11-24 | 1994-11-22 | Inhibition of smooth muscle migration and proliferation with hydroxy carbazole compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE226072T1 true ATE226072T1 (en) | 2002-11-15 |
Family
ID=22564393
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95902689T ATE226072T1 (en) | 1993-11-24 | 1994-11-22 | INHIBITING SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXYCARBAZOLE COMPOUNDS |
Country Status (12)
Country | Link |
---|---|
US (1) | US5393772A (en) |
EP (1) | EP0741567B1 (en) |
JP (1) | JPH09505809A (en) |
KR (1) | KR100386229B1 (en) |
CN (1) | CN1102388C (en) |
AT (1) | ATE226072T1 (en) |
AU (1) | AU686706B2 (en) |
CA (1) | CA2176377A1 (en) |
DE (1) | DE69431568T2 (en) |
ES (1) | ES2185691T3 (en) |
WO (1) | WO1995014384A1 (en) |
ZA (1) | ZA949246B (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5811447A (en) * | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6395494B1 (en) | 1993-05-13 | 2002-05-28 | Neorx Corporation | Method to determine TGF-β |
US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6306421B1 (en) | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
US6663881B2 (en) | 1993-01-28 | 2003-12-16 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5595722A (en) * | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
ATE406909T1 (en) * | 1993-05-13 | 2008-09-15 | Poniard Pharmaceuticals Inc | PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS |
US20030083733A1 (en) * | 1997-10-10 | 2003-05-01 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5837313A (en) * | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US20020091433A1 (en) * | 1995-04-19 | 2002-07-11 | Ni Ding | Drug release coated stent |
US6099562A (en) * | 1996-06-13 | 2000-08-08 | Schneider (Usa) Inc. | Drug coating with topcoat |
US7611533B2 (en) * | 1995-06-07 | 2009-11-03 | Cook Incorporated | Coated implantable medical device |
ZA967892B (en) * | 1995-09-21 | 1998-03-18 | Lilly Co Eli | Selective β3 adrenergic agonists. |
AU4083097A (en) * | 1996-08-23 | 1998-03-06 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership No. 1 | Method for inhibiting the expression of fas |
US5808080A (en) | 1996-09-05 | 1998-09-15 | Eli Lilly And Company | Selective β3 adrenergic agonists |
ATE215369T1 (en) * | 1996-09-05 | 2002-04-15 | Lilly Co Eli | CARBAZOLE ANALOGUES AS SELECTIVE BETA3-ADRENERGIC AGONISTS |
PL332638A1 (en) | 1996-10-09 | 1999-09-27 | Boehringer Mannheim Pharm Corp | Method of inhibiting stress-activated proteinous kinases |
AU765934B2 (en) * | 1996-10-09 | 2003-10-02 | Boehringer Mannheim Pharmaceuticals Corporation-Smithkline Beecham Corporation Limited Partnership No. 1 | Method for inhibiting stress-activated protein kinases |
CO5011072A1 (en) | 1997-12-05 | 2001-02-28 | Lilly Co Eli | ETANOLAMINAS PIRAZINIL SUBSTITUTED AS AGFONISTS OF THE RECEPTORS |
DE19830472B4 (en) * | 1998-07-08 | 2013-06-27 | Robert Bosch Gmbh | External component for a microprocessor system and operating procedures |
US20040243097A1 (en) * | 2000-05-12 | 2004-12-02 | Robert Falotico | Antiproliferative drug and delivery device |
US8236048B2 (en) * | 2000-05-12 | 2012-08-07 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US20050002986A1 (en) * | 2000-05-12 | 2005-01-06 | Robert Falotico | Drug/drug delivery systems for the prevention and treatment of vascular disease |
US8303609B2 (en) * | 2000-09-29 | 2012-11-06 | Cordis Corporation | Coated medical devices |
US20020051730A1 (en) * | 2000-09-29 | 2002-05-02 | Stanko Bodnar | Coated medical devices and sterilization thereof |
US20020111590A1 (en) * | 2000-09-29 | 2002-08-15 | Davila Luis A. | Medical devices, drug coatings and methods for maintaining the drug coatings thereon |
US7261735B2 (en) * | 2001-05-07 | 2007-08-28 | Cordis Corporation | Local drug delivery devices and methods for maintaining the drug coatings thereon |
US6613083B2 (en) * | 2001-05-02 | 2003-09-02 | Eckhard Alt | Stent device and method |
US7195640B2 (en) * | 2001-09-25 | 2007-03-27 | Cordis Corporation | Coated medical devices for the treatment of vulnerable plaque |
US20030065377A1 (en) * | 2001-09-28 | 2003-04-03 | Davila Luis A. | Coated medical devices |
DE60221683T2 (en) * | 2001-09-28 | 2008-04-30 | F. Hoffmann-La Roche Ag | PSEUDOPOLYMORPHIC FORMS OF CARVEDILOL |
US7108701B2 (en) * | 2001-09-28 | 2006-09-19 | Ethicon, Inc. | Drug releasing anastomosis devices and methods for treating anastomotic sites |
US20030065345A1 (en) * | 2001-09-28 | 2003-04-03 | Kevin Weadock | Anastomosis devices and methods for treating anastomotic sites |
US8101209B2 (en) * | 2001-10-09 | 2012-01-24 | Flamel Technologies | Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles |
EP1499310A4 (en) * | 2002-04-30 | 2005-12-07 | Sb Pharmco Inc | Carvedilol monocitrate monohydrate |
CN103254114A (en) * | 2002-06-27 | 2013-08-21 | 史密斯克莱.比奇曼(科克)有限公司 | Carvedilol phosphate salts and/or solvates thereof, correspondinq compositions, and/or methods of treatment |
JP2005533822A (en) * | 2002-06-27 | 2005-11-10 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | Carvedilol hydrobromide |
US8734850B2 (en) * | 2003-11-25 | 2014-05-27 | Flamel Technologies | Oral medicinal product with modified release of at least one active principle in multimicrocapsular form |
JP2007512372A (en) * | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | Carvedilol salts, corresponding compositions, delivery and / or treatment methods |
JP2007512350A (en) * | 2003-11-25 | 2007-05-17 | エスビー・ファルムコ・プエルト・リコ・インコーポレイテッド | Carvedilol composition treatment and delivery methods |
US10281374B2 (en) * | 2015-11-04 | 2019-05-07 | Diagnostic Biosystems | Method of pretreatment of biological samples for an analyte-staining assay method |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2815926A1 (en) * | 1978-04-13 | 1979-10-18 | Boehringer Mannheim Gmbh | NEW CARBAZOLYL- (4) -OXY-PROPANOLAMINE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
US5308862A (en) * | 1993-03-05 | 1994-05-03 | Boehringer Mannheim Pharmaceuticals Corporation - Smithkline Beecham Corp., Ltd. Partnership No. 1 | Use of, and method of treatment using, carbazolyl-(4)-oxypropanolamine compounds for inhibition of smooth muscle cell proliferation |
-
1993
- 1993-11-24 US US08/157,588 patent/US5393772A/en not_active Expired - Lifetime
-
1994
- 1994-11-22 ES ES95902689T patent/ES2185691T3/en not_active Expired - Lifetime
- 1994-11-22 CN CN94194188A patent/CN1102388C/en not_active Expired - Fee Related
- 1994-11-22 KR KR1019960702460A patent/KR100386229B1/en not_active IP Right Cessation
- 1994-11-22 ZA ZA949246A patent/ZA949246B/en unknown
- 1994-11-22 CA CA002176377A patent/CA2176377A1/en not_active Abandoned
- 1994-11-22 WO PCT/US1994/013561 patent/WO1995014384A1/en active IP Right Grant
- 1994-11-22 JP JP7515231A patent/JPH09505809A/en active Pending
- 1994-11-22 DE DE69431568T patent/DE69431568T2/en not_active Expired - Fee Related
- 1994-11-22 AU AU11867/95A patent/AU686706B2/en not_active Ceased
- 1994-11-22 EP EP95902689A patent/EP0741567B1/en not_active Expired - Lifetime
- 1994-11-22 AT AT95902689T patent/ATE226072T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US5393772A (en) | 1995-02-28 |
DE69431568D1 (en) | 2002-11-21 |
AU1186795A (en) | 1995-06-13 |
ZA949246B (en) | 1995-07-04 |
EP0741567B1 (en) | 2002-10-16 |
DE69431568T2 (en) | 2003-06-26 |
CN1135161A (en) | 1996-11-06 |
JPH09505809A (en) | 1997-06-10 |
WO1995014384A1 (en) | 1995-06-01 |
KR100386229B1 (en) | 2003-08-21 |
CA2176377A1 (en) | 1995-06-01 |
EP0741567A1 (en) | 1996-11-13 |
CN1102388C (en) | 2003-03-05 |
ES2185691T3 (en) | 2003-05-01 |
EP0741567A4 (en) | 1996-12-04 |
AU686706B2 (en) | 1998-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE226072T1 (en) | INHIBITING SMOOTH MUSCLE MIGRATION AND PROLIFERATION WITH HYDROXYCARBAZOLE COMPOUNDS | |
ATE181551T1 (en) | TAXOL DERIVATIVES | |
TW325458B (en) | Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer | |
DE69831937D1 (en) | BICYCLIC PROTEIN-FARNESYL-TRANSFERASE INHIBITORS | |
MY108885A (en) | Heterocyclic-cyclic amine derivatives. | |
MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
ZA947970B (en) | Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases | |
LU88749I2 (en) | TACRINE and its pharmaceutically acceptable derivatives (COGNEX) | |
CA2122360A1 (en) | Quinazolinone Antianginal Agents | |
DK0687260T3 (en) | Process for the preparation of 9-deoxotaxanes | |
DE69827777D1 (en) | Delayed-release compositions for the treatment of hyperlipidemia | |
AU2534295A (en) | Gastrin and cck antagonists | |
AR038433A2 (en) | DERIVATIVES 2-RENT-2-DESOXO OF PARAHERCUAMIDA AND MARCFORTINA | |
DE69227088T2 (en) | Use of 1- (aminoalkyl) -3-quinoxalin-2-one derivatives for the production of neuroprotective agents | |
AU5819794A (en) | Piperazine derivatives | |
DK0547545T3 (en) | Pharmaceutical composition for inhibiting bone resorption | |
FI964045A (en) | CCK or gastrin regulating 5-heterocycle-1,5-benzodiazepines | |
WO1998023244A3 (en) | Intracoronary stents containing quinazolinone derivatives | |
GR1002598B (en) | Epi-epibatidine derivatives. | |
DE69405760T2 (en) | 4-AZA-PREGNAN-5-ALPHA REDUCTASE ISOZYM 1 INHIBITORS | |
NO994902L (en) | Breast cancer prevention by selective estrogen receptor modulators | |
ES2184885T3 (en) | AZA-ANTHRACICLINONE DERIVATIVES. | |
FI964278A (en) | Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivative | |
ATE63309T1 (en) | 2,3-DIHYDRO-2-OXO-3-BENZOFURANYLESSIGS|UREDERIVATE AND PHARMACEUTICALS CONTAINING THEM. | |
DE69708645T2 (en) | USE OF ASPIROCHLORINE OR DERIVATIVES FOR IMMUNE SUPPRESSION |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |